Derek Robinson

Title: The Innovations of Derek Robinson

Introduction

Derek Robinson is an accomplished inventor based in Boxford, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of recombinant DNA technology. With a total of 2 patents to his name, Robinson's work has advanced our understanding of restriction endonucleases and their applications.

Latest Patents

Robinson's latest patents include a method for cloning and expression of Tth111II restriction endonuclease-methylase in E. coli. This invention relates to recombinant DNA that encodes the Tth111II restriction endonuclease-methylase fusion protein (Tth111IIRM). It also covers the expression of this fusion protein in cells containing the recombinant DNA, as well as the purification of Tth111II endonuclease-methylase fusion protein to near homogeneity. Another notable patent is for a novel type II restriction endonuclease, APO I, obtainable from Arthrobacter protophormiae. This endonuclease recognizes a specific nucleotide sequence and has a defined cleavage point, with a detailed process for obtaining Apo I from the source organism.

Career Highlights

Derek Robinson is currently employed at New England Biolabs, Inc., a leading company in the field of molecular biology. His work at this organization has allowed him to further his research and contribute to innovative solutions in biotechnology.

Collaborations

Robinson has collaborated with notable coworkers such as Carol Polisson and Keith D Lunnen. These partnerships have likely enriched his research and contributed to the success of his inventions.

Conclusion

Derek Robinson's contributions to biotechnology through his patents and work at New England Biolabs, Inc. highlight his role as a significant inventor in the field. His innovative approaches to recombinant DNA technology continue to influence the scientific community.